case studies

Shaping Policy to Accelerate a Rare Kidney Disease Treatment Revolution

Travere-Tx-Inline-fullcolor

Travere Therapeutics

the challenge

New scientific advances and regulatory flexibility sparked a wave of innovation in rare kidney disease, which had seen no new treatments in 80 years. Travere Therapeutics engaged CURA for several projects over the last five years to educate public and private policymakers and influencers. Through stakeholder roundtables, consensus reports, Hill events and issue briefs, CURA has helped champion the New Era of Preventing End-Stage Kidney Disease Act.

The Solution

Screenshot 2026-02-19 at 12.27.55 PM

Synthesized input from over 40 stakeholders across three workgroups (insurance, innovation, DEI) to develop and design a policy playbook for revolutionizing rare kidney disease.

TravereImage6

Coordinated a virtual event to promote the playbook that included live and pre-recorded messages from congressional members and advocacy leaders.

Nephcure2018_157

Organized a multi-stakeholder roundtable to identify collaborative opportunities for accelerating rare disease diagnosis and treatment

Helm Quote IG

Created report landing pages with patient videos and promoted through stakeholder toolkits, social media and paid ads.

TravereImage7

Organized a reception on Capitol Hill with patient advocates to educate policymakers on the experiences and unmet needs of rare kidney patients.

The Results

7,700 unique visitors to landing page
10% conversion rate in paid and organic campaigns
The New Era of Preventing End-Stage Kidney Disease Act (H.R. 6790)

was introduced to Congress with 38 co-sponsors

50+ attendees

at a reception on Capitol Hill, including policymakers, staffers and advocates

800 downloads

of We Deserve Better Report

TravereImage8

Key Services

Content development & design Digital marketing Event planning & support Focus group management Landing page development Stakeholder engagement
View More Services
services-image-placeholder-3

“CURA’s understanding of the healthcare landscape and extensive experience working with the full spectrum of healthcare stakeholders sets them apart. From strategic planning and managing complex multi-stakeholder coalitions to simple policy one-pagers, CURA delivers. Real professionals with great results. I highly recommend.”

Chris Porter, Vice President, Government Affairs and Policy
Travere Therapeutics
Let's get started

Ready to Transform Health Care?

Contact Us